Skip to content
Medical Health Aged Care

RACGP welcomes free RSV vaccinations for older Western Australians

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has welcomed the Western Australian Government’s announcement that older Western Australians living in residential aged care will receive free RSV immunisation through a new $2.6 million state-funded program.

For the first time, the Arexvy RSV vaccine, which normally costs around $300 privately, will be made available at no cost to Western Australians aged 65 and over residing in aged care facilities. The Department of Health estimates 15,000 aged care residents will be vaccinated this year.

The RACGP has long advocated for equitable access to immunisation for older Australians, particularly those in aged care where the burden of respiratory illness is highest.

RSV is a highly contagious respiratory virus that can cause severe illness in older adults, particularly those with existing cardiac or respiratory conditions or weakened immune systems. In 2025, Western Australia recorded 12,804 RSV cases, with around one third occurring in people aged over 65, many of whom required hospital care.

RACGP WA Chair Dr Ramya Raman welcomed the initiative as a vital step in protecting vulnerable older Western Australians and alleviating pressure on the health system.

“This is a significant and much needed investment in preventive healthcare for older Western Australians,” she said.

“RSV can be life-threatening for older adults, particularly those in aged care. Providing this vaccine free of charge will prevent serious illness, reduce hospital admissions, and protect residents who are most at risk.

“GPs see firsthand the impact that respiratory infections have every winter. A free RSV vaccine program for older adults, alongside WA’s successful infant immunisation program, strengthens protection across generations and fosters healthier communities.

“The RACGP has been advocating to the government on RSV vaccinations for some time, and we are delighted to see the Cook government deliver on this priority.”

Dr Raman highlighted the broader benefits for system-wide resilience during peak winter demand.

“Vaccination remains one of the most effective ways to prevent avoidable hospital presentations,” she said.

“This initiative will protect individuals while easing pressure on emergency departments and hospital wards when they are busiest.

“The RACGP welcomes the Cook Government’s commitment to preventive health. Offering free, evidence-based access to high-quality vaccines for vulnerable groups is a smart investment that will save lives and strengthen our entire health system.”

The RACGP looks forward to working with the WA Government, aged care providers, and primary care clinicians to ensure a smooth rollout of the program across the state.

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Biotechnology, Medical Health Aged Care
  • 19/02/2026
  • 12:50
Q-Sera

Improving laboratory management and patient outcomes – Q-Sera announces first product launch of its RAPClot(TM) rapid serum blood collection tube technology in Japan

Melbourne, Australia – February 19, 2026 – Q-Sera Pty Ltd, an Australian venture-backed company, today announced that leading Japanese medical device company, Terumo Corporation has launched VenoJect II RAPClotTM evacuated blood collection tubes in the Japanese market. These next-generation tubes incorporate Q-Sera’s patent protected technology and will improve laboratory management and patient outcomes. Even in anticoagulated blood, RAPClot™ rapid serum tubes rapidly produce high quality serum in five minutes. In the case of the VenoJect II RAPClot tubes, formulated to clot up to 6U/ml heparin. This is the first real innovation in the Japanese blood collection tube market in decades,…

  • Medical Health Aged Care
  • 18/02/2026
  • 14:49
Dementia Australia

Get active for your brain health and beat dementia in Adelaide!

The 2026 Adelaide Memory Walk & Jog is just weeks away, with the event taking place on Sunday 15 March at Wigley Reserve, Glenelg. As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers. More than 35,800 people are living with dementia in South Australia.Dementia is now the leading cause of death for Australians, and without significant intervention, the number of Australians living with dementia is projected to more than double to over one million people by 2065. In 2026, 14…

  • Contains:
  • General News, Medical Health Aged Care
  • 18/02/2026
  • 13:44
GMHBA

With the lowest premium rise in the industry, GMHBA keeps premium increases below industry average for fourth year running

With the lowest premium rise in the industry, GMHBA keeps premium increases below industry average for fourth year running GMHBA Ltd average premium increase…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.